Clinical Trial: Biomarkers in Samples From Patients With Down Syndrome and Acute Megakaryoblastic Leukemia

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Development of Novel Therapeutics for AMKL

Brief Summary:

RATIONALE: Studying samples of blood or tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in samples from patients with Down syndrome and acute megakaryoblastic leukemia.